New Treatment Guidelines for Sjögren's Disease

Frederick B Vivino; Steven E Carsons; Gary Foulks; Troy E Daniels; Ann Parke; Michael T Brennan; S Lance Forstot; R Hal Scofield; Katherine M Hammitt

doi:10.1016/j.rdc.2016.03.010

New Treatment Guidelines for Sjögren's Disease

Rheum Dis Clin North Am. 2016 Aug;42(3):531-51. doi: 10.1016/j.rdc.2016.03.010.

Authors

Frederick B Vivino¹, Steven E Carsons², Gary Foulks³, Troy E Daniels⁴, Ann Parke⁵, Michael T Brennan⁶, S Lance Forstot⁷, R Hal Scofield⁸, Katherine M Hammitt⁹

Affiliations

¹ Division of Rheumatology, Penn Presbyterian Medical Center, Penn Sjögren's Center, Penn Medicine University City, University of Pennsylvania, 3737 Market Street, Philadelphia, PA 19104, USA. Electronic address: frederick.vivino@uphs.upenn.edu.
² Division of Rheumatology, Allergy and Immunology, Winthrop University Hospital, 120 Mineola Boulevard, Suite 410, Mineola, NY 11501, USA; Stony Brook University School of Medicine, Stony Brook, 120 Mineola Boulevard, Mineola, NY 11501, USA.
³ Department of Ophthalmology and Vision Science, University of Louisville School of Medicine, 301 East Muhammad Ali Boulevard, Louisville, KY 40202, USA.
⁴ Department of Orofacial Sciences, UCSF Schools of Dentistry and Medicine, 521 Parnassus Avenue, Clinic Sci, San Francisco, CA 94143, USA.
⁵ Division of Rheumatology, St. Francis Hospital & Medical Center, 114 Woodland Street, Hartford, CT 06105, USA.
⁶ Department of Oral Medicine, Carolinas Medical Center, 1000 Blythe Boulevard, Charlotte, NC 28203, USA.
⁷ Corneal Consultants of Colorado, 8381 Southpark Lane, Littleton, CO 80120, USA.
⁸ Department of Veterans Affairs, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, 1000 North Lincoln Boulevard, #2900, Oklahoma City, OK 73104, USA.
⁹ Sjögren's Syndrome Foundation, 6707 Democracy Boulevard, Suite 325, Bethesda, MD 20817, USA.

Abstract

Sjögren's disease is associated with a high burden of illness, diminished quality of life, and increased health care costs. The Sjögren's Syndrome Foundation developed the first US clinical practice guidelines for management of the oral, ocular, and rheumatologic or systemic manifestations. Guideline recommendations were reviewed by a consensus expert panel using a modified Delphi process. This initiative should improve the quality and consistency of care for Sjögren's disease in the United States, guide insurance reimbursement, and define areas for future study. Guidelines will be periodically reviewed and revised as new information becomes available.

Keywords: Arthritis; Biologics; Caries; DMARDS; Dry eye; Fatigue; Sjögren's; Treatment.

Publication types

Review

MeSH terms

Antirheumatic Agents / therapeutic use*
Biological Products / therapeutic use*
Cariostatic Agents / therapeutic use
Cost of Illness
Delphi Technique
Dental Caries / etiology
Dental Caries / prevention & control
Exercise Therapy
Fatigue / etiology
Fatigue / therapy
Fluorides / therapeutic use
Health Care Costs
Humans
Hydroxychloroquine / therapeutic use
Practice Guidelines as Topic
Quality of Life
Rituximab / therapeutic use
Self Care
Severity of Illness Index
Sjogren's Syndrome / drug therapy*

Substances

Antirheumatic Agents
Biological Products
Cariostatic Agents
Rituximab
Hydroxychloroquine
Fluorides

Abstract

Publication types

MeSH terms

Substances

Grants and funding